C

CureVac

Tubingen, Germany Founded 2000 NASDAQ: CVAC

About

Pioneer in mRNA technology using lipid nanoparticle delivery for vaccines and therapeutics

Company Details

Type
commercial
Employees
500-1000
Funding
Public

Key Products

  • mRNA Technology Platform
Visit Website

Related Companies